Compare GSK plc (GSK) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Riot Platforms Inc — how do they compare? GSK plc trades at $52.67 (market cap $101.34B), while Riot Platforms Inc trades at $18.48 (market cap $7.60B). The key difference: GSK plc is far larger — about 13.3× Riot Platforms Inc's market cap, and GSK plc pays a 3.49% dividend while Riot Platforms Inc pays none. Which is the better fit depends on your goals.
| GSK | RIOT | |
|---|---|---|
Market Cap | $101.34B | $7.60B |
Sector | Health | Technology |
52-Week High | $61.18 | $28.67 |
52-Week Low | $36.20 | $11.03 |
Enterprise Value | $121.95B | $8.27B |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
RIOT trades at $18.89, down 6.44% over 24 hours, with a bearish technical signal from moving averages. The company reported a net loss of $663.18M in 2025 despite $647.44M revenue, reflecting negative profit margins. Recent earnings missed expectations in Q4 2025 and Q1 2026. Analyst consensus remains strongly bullish with a $27.86 price target, supported by 17 buy ratings. News highlights volatility amid Bitcoin price swings and Texas grid reliability concerns affecting data center operations.
Outlook is mixed: strong analyst support suggests upside potential, but persistent losses and operational cash flow deficits pose significant risks. Investors face exposure to cryptocurrency market volatility and execution challenges in expanding high-performance compute capacity. The stock's current price near support levels may attract buyers if fundamentals improve.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
